Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer
Background The current challenge for immunotherapies is to generate effective antitumor immunity. Since tumor immune escape mechanisms do not impact pre-existing and consolidated immune responses, we tested the hypothesis of redirecting a pregenerated immunity to cancer: to recall a non-tumor antige...
Saved in:
Main Authors: | Luca Mastracci, Patrizio Castagnola, Elia Bari, Francesca Ferrera, Tiziana Altosole, Sara Perteghella, Pierluigi Mauri, Rossana Rossi, Giulia Passignani, Martina Galati, Giuseppina Iliana Astone, Maddalena Mastrogiacomo, Daniela Fenoglio, Dario Di Silvestre, Maria Luisa Torre, Gilberto Filaci |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e005916.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Trojan Horse in the Citadel of Stories?
by: Hartley John
Published: (2013-12-01) -
JWST Near-infrared Spectroscopy of High-albedo Jupiter Trojans: A New Surface Type in the Trojan Belt
by: Michael E. Brown, et al.
Published: (2025-01-01) -
Food Antimicrobials Nanocarriers
by: Adriana Blanco-Padilla, et al.
Published: (2014-01-01) -
The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
by: Delia Nelson, et al.
Published: (2014-01-01) -
Human parietal epithelial cells as Trojan horses in albumin overload
by: Giovanna Priante, et al.
Published: (2025-01-01)